Advertisement

Search Results for "ranbaxy"

Forbes List Logo
Under Whose Watch Did The Ranbaxy Fraud Happen?
ByRohin Dharmakumar
It's not just Ranbaxy, our health care regulators have failed us too
BySeema Singh
Ranbaxy: Nowhere to Hide
ByMalini Goyal,T Surendar
Sun Has a Better Shot Than Most at Ranbaxy Turnaround
ByPriyanka Pulla
Katherine Eban: Ranbaxy and the dark side of Indian pharma
ByPooja Sarkar
Daiichi could be the biggest beneficiary of the Sun Pharma-Ranbaxy deal
BySalil Panchal
Analjit Singh’s Future-Proof Strategy
ByPrince Mathews Thomas
Ranbaxy: Nowhere to Hide
ByMalini Goyal
India's 'pharmacy of the world' moniker is under threat. Here's why
ByNaini Thaker
No incentive for quality in generic drugs world: Katherine Eban
ByPooja Sarkar
India's Richest 2019: A giant leap for Mankind
ByRajiv Singh
Mergers and Acquisitions: Outlook in India for 2018
ByAshish Parwani, Rajeev Nair and Gitika Makhija
Why whistle blowing is so hard in India
ByNitin Paranjpe

Latest News

Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Synthetic Data: The new backbone of next gen cybersecurity
ByIIM Calcutta
Change maker companies in India
ByBrand Connect
Advertisement
Advertisement

On Everyone’s Radar

Advertisement